作者：
Johnston,S.R.D. [1]
;
Kilburn,L.S. [2]
;
Ellis,P. [3]
;
Dodwell,D. [4]
;
Cameron,D. [5]
;
Hayward,L. [6]
;
Im,Y.-H. [7]
;
Braybrooke,J.P. [8]
;
Brunt,A.M. [9]
;
Cheung,K.-L. [10]
;
Jyothirmayi,R. [11]
;
Robinson,A. [12]
;
Wardley,A.M. [13]
;
Wheatley,D. [14]
;
Howell,A. [15]
;
Coombes,G. [16]
;
Sergenson,N. ;
Sin,H.-J. ;
Folkerd,E. ;
Dowsett,M. ;
Bliss,J.M.
作者单位：
Royal Marsden NHS Foundation Trust, London, United Kingdom
[1]
Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, United
[2]
King's Health Partners, London, United Kingdom
[3]
Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds, United Kingdom
[4]
University of Edinburgh and NHS Lothian, Edinburgh, United Kingdom
[5]
Western General Hospital, Edinburgh, United Kingdom
[6]
Samsung Medical Center, Seoul, South Korea
[7]
Bristol Haematology and Oncology Centre, Bristol, United Kingdom
[8]
University Hospital of North Staffordshire, Stoke-on-Trent, United Kingdom
[9]
Nottingham University Hospitals, Nottingham, United Kingdom
[10]
Kent Oncology Centre, Maidstone, United Kingdom
[11]
The Christie NHS Foundation Trust, Manchester, United Kingdom
[12]
Royal Cornwall Hospital, Truro, United Kingdom
[13]
Cancer Clinical Trials Team, Information Services Division, Edinburgh, United Kingdom
[14]
AstraZeneca Korea, Seoul, South Korea
[15]
Southend Hospital, Southend, United Kingdom
[16]
发布时间
2022-09-09
换一批
